For this year’s poster presentation, abstracts were submitted by undergraduate students, graduate students, post-doctoral scholars, residents, and associate fellows. Each poster was judged on ...

Poster Presentation at the Annual Meeting of The Society of Nuclear Medicine, Salt Lake City, UT, June 6-9, 2010. Shah R, Borghei P, Patel B, Palmer C, Cure J. Utility of serial lesion quotient ...

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...

MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced three poster presentations at the 2025 American ...

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP ...